Dr. Goldstein is a member of the National Academy of Sciences, the National Academy of Medicine and the Royal Society of London. Before joining Regeneron, Christina served as vice president, global finance communication at Johnson & Johnson (J&J). Dr. Braunstein received his B.S. Dr. Bassler currently serves on the board of directors of Kaleido Biosciences, Inc., Cidara Therapeutics, Inc. and Royalty Pharma plc. The pharmacometric functions are also responsible for the associated documentation needed to support clinical protocols, as well as the nonclinical PK and clinical pharmacology summaries for the global regulatory filings. para informarnos de que tienes problemas. A certified DE&I professional, Ms. Pillai received her BBA from KS School of Management and her MBA from Symbiosis International Business School, India. Se continui a visualizzare in molecular biology and A.B. Before joining the pharmaceutical industry, Dr. Hughes worked as a medical practitioner in the UK and U.S. Dr. Hughes earned a medical degree (MBBS) from The Royal Free Hospital and School of Medicine, London University, and an M.Sc. Regental Professor and Chairman, Department of Molecular Genetics, The University of Texas Southwestern Center at Dallas. $2.8M. Benjamin Drosman joined Regeneron in 2010 and serves as senior vice president, global development quality & regulatory compliance. las molestias. ein Mensch und keine Maschine sind. She has been a key contributor to developing Regenerons groundbreaking VelociSuite of genomics technologies, including playing a critical role in developing VelociGene, and subsequently working as part of a team that developed the VelocImmune Mouse. degree from New York University. Thank you to our incredible colleagues for making this truly a great place to work and a place where passion meets opportunity. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. Executive Vice President and General Manager, Industrial Operations and Product Supply. from the University of Rochester and a Ph.D. from State University of New York. She received her B.S. The estimated base pay is $208,591 per year. Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie How much do Regeneron employees make? , excuses voor het ongemak. The estimated base pay is $204,976 per year. Before joining Regeneron, Dr. Hirshberg was executive vice president, chief medical officer and head of global development at BOL Pharma, a biotech developing medical cannabis therapeutics, where he directed preclinical and clinical development, regulatory, pharmacovigilance and medical affairs. The average Regeneron salary ranges from approximately $52,103 per year for a Research Assistant to $376,244 per year for a Senior Director. and Ph.D. in chemical engineering from Danmarks Tekniske Universitet (Technical University of Denmark). Regeneron Pharmaceuticals: Delivering Life-transforming Medicines Push the bounds of science Make life-changing medicines Pause Regeneron News: Feb 23rd Aflibercept 8 mg BLA for Treatment of Wet Age-Related Macular Degeneration and Diabetic Macular Edema Accepted for FDA Priority Review Follow us: Now approved for a new indication Now approved for Aydanos a proteger Glassdoor y demustranos que eres una persona real. Mr. Yocums broad knowledge and expertise in Good Manufacturing Practices (GMP) and processes have contributed to the successful launch of every Regeneron commercial product. GSK Brown and Goldstein jointly received the Nobel Prize for Physiology or Medicine in 1985 and the U.S. National Medal of Science in 1988. Dr. Lancaster received his BSc in pharmacology and his M.D. She is a former member of the supervisory board of Royal Philips Electronics and the board of directors of Decibel Therapeutics, Inc. He is a primary architect of Regenerons cancer immunotherapy program. from Virginia Polytechnic Institute and State University. OR. in medicine and his M.D. Senior Vice President, Technical Operations. Abbott The average Regeneron salary ranges from approximately $52,103 per year for a Research Assistant to $376,244 per year for a Senior Director. Disculpa He received his B.A. The lowest-paying job at Regeneron is a Research Assistant with a salary of $52,103 per year. Each salary is associated with a real job position. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. The highest-paying job at Regeneron is a Senior Director with a salary of $376,244 per year. The estimated additional pay is $210,764 per year. Senior Vice President, Strategic Alliances. Prior to joining Regeneron, Dr. Macdonald worked for Cadus Pharmaceuticals after completing a post-doctoral fellowship at Columbia University. Overall Benefits Rating.css-11cfy92{color:#0caa41 !important;}.css-11cfy92{color:#0caa41 !important;}4.1, Matches half of your contribution up to 5% (of gross pay) on 10%. Feb 1, 2023 11:58am. He has served as the president and chief executive officer of Cerevel Therapeutics Holdings, Inc., the parent entity of Cerevel Therapeutics, Inc. since 2019, and as chair of Cerevel Therapeutics Holdings, Inc. since 2018. Prior to joining Regeneron, Mr. Drosman worked at Pfizer for 12 years holding various positions of increasing responsibility in pharmacovigilance, quality assurance and regulatory strategy. from Siena College and his MBA from State University of New York at Albany. He completed his post-doctoral studies at the University of Pennsylvania. Chief Diversity, Equity and Inclusion Officer. verdade. She earned a B.S. Senior Vice President, Associate General Counsel. Thorough reviews have been conducted to assure this data accurately reflects disclosures. Dr. Soltys received his B.S. Melissa Lozner, J.D., joined Regeneron in 2022 and serves and as senior vice president, chief compliance officer. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. For its 2021 fiscal year, REGENERON PHARMACEUTICALS, INC., listed the following board members on its annual proxy statement to the SEC. Compensation data tools, salary structures, surveys and benchmarks. in international relations and Chinese from Tufts University. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. He is also a regental professor of molecular genetics and internal medicine and the director of the Jonsson Center for Molecular Genetics at the UT Southwestern Medical Center at Dallas, positions he has held since 1985. degree from Duke University and his Ph.D. in biochemistry from Brandeis University, then conducted post-doctoral research and was a faculty member at the University of California, San Francisco. A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. On Fishbowl, you can share insights and advice anonymously with Regeneron employees and get real answers from people on the inside. Ms. McCourt began her career and spent 12 years at AstraZeneca, ultimately becoming chief operating officer for AstraZeneca U.S. She received her B.S. Dr. Weinreich also previously served as vice president of clinical affairs at Gene Logic and as an independent consultant, helping small- to mid-stage biotechnology companies with drug commercialization. Thank you to our incredible colleagues for making this truly a great place to work and a place where passion meets opportunity. Dr. Thompson is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the Association of American Physicians. The top 10% of employees earn more than $139k per year. at New York Medical College and a Ph.D. from Saint Johns University. It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. About the VP of Engineering Role: We are looking for an experienced VP of Engineering with a strong technical background from a product development company and, ideally, ERP product development Be the first to add REGENERON PHARMACEUTICALS, INC. Vice President of Laboratory responsibilities. Our company is built on breakthrough ideas; which is why we foster a spirit of.css-epvm6{white-space:nowrap;} More, Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Additional pay could include bonus, stock, commission, profit sharing or tips. Regeneron salary trends based on salaries posted anonymously by Regeneron employees. As Executive Vice President, Research at REGENERON PHARMACEUTICALS, INC., Andrew J. Murphy Ph.D. made $7,146,830 in total compensation. Gilead The estimated total pay for a Vice President Operations at Regeneron is $448,608 per year. The average Regeneron hourly pay ranges from approximately $24 per hour for an Intern - Hourly to $148 per hour for a Director. Executive Vice President, Functional Genomics and Chief VelociGene Operations. Mr. OLeary received his B.S. Prior to joining Fisher, Ms. Poon was vice chair, worldwide chair of pharmaceuticals, member of the executive committee and director at Johnson & Johnson. Mr. Brooks leads a team responsible for optimizing liquidity and use of capital resources, safeguarding Regenerons cash and investment portfolio, corporate risk management and maintaining strong relationships with financial institutions, insurance providers and rating agencies. from the University of Connecticut. 4 percents of the salary are above $200K, 15 percents of the salary are between $150K and $200K, 56 percents of the salary are between $100K and $150K, 25 percents of the salary are less than $100k We found the records are from 1 employers: Drs. , GSK She earned a B.S. Biogen and Ph.D. in chemical engineering from the University of Virginia. Average salary for AstraZeneca Vice President Finance in Seaham, England: [salary]. Senior Vice President, Head of Accounting and Controller. Gregory Geba, M.D., Ph.D., joined Regeneron in 2013 and serves as senior vice president of the global development scientific council, a group that provides senior scientific input to Regenerons therapeutic portfolio of programs. The community relies on everyone sharing. In addition, his team oversees regulatory functions including labeling and advertising/promotion and compliance. from Boston University School of Law. Lamentamos pelo inconveniente. How much do Regeneron employees make? CA. #GlassdoorBPTW, We are excited to share that for the second year in a row, BioSpace has named us a Best Place to Work. Prior to this role, he was senior vice president, late stage clinical development and medical affairs. From 2008 to 2015, Dr. Herman was one of only three pharmaceutical industry members on the Executive Committee of the Biomarkers Consortium, a program within the Foundation for the National Institutes of Health. in biochemistry and cell biology from the University of California, San Diego, and his M.D. Find high paying available jobs at Regeneron Pharmaceuticals, Inc.For expert network information on Regeneron Pharmaceuticals, Inc compensation and careers, use Ladders $100K + Club. Joseph J. LaRosa joined Regeneron in 2011 and is currently executive vice president, general counsel and secretary. How much do Regeneron employees make? from Douglass College of Rutgers University and a Ph.D. from the University of North Carolina at Chapel Hill. Ms. Ravetti leads the Global Pharmaceutical Legal Operations team, a multidisciplinary team providing legal advice on the clinical development and commercialization of Regenerons products,including advice on R&D, regulatory matters, market access, product launches, lifecycle planning, and healthcare law compliance. Dr. Hirshberg completed his undergraduate and medical degrees at the Hebrew University and is board certified in internal medicine, following his residency at the Hadassah Medical center in Jerusalem. Dr. Reinertsen started her biotech career at Millennium Pharmaceuticals (now Takeda Oncology) where she held positions of increasing responsibility in business development. Abbvie Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. in computer engineering from Columbia University, his MBA from the McDonough School of Business at Georgetown University and his M.D. Executive Vice President, Finance and Chief Financial Officer. Drs. Bonus. Christos Kyratsous, Ph.D., joined Regeneron in 2011 and is the senior vice president of research. Dr. Zoghbi has been a director of the company since 2016. He has held leadership positions of increasing responsibility in quality, regulatory affairs, program management and manufacturing across biological, small molecule and medical device platforms. Amgen Prior to Regeneron, Mr. Carreau worked at Novartis (formerly Chiron Corporation). Andrew Murphy, Ph.D., joined Regeneron in 1999 as director of genomics and bioinformatics and is now executive vice president of research. Ron Wang, Ph.D., joined Regeneron in 1999 andcurrentlyserves as senior vice president of quality control, leading a global functionthat leveragesstrategic business partnerships and automation to provide back-up lab capabilities,protect the supply chain and optimize resources and lab capacity. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema (DME); myopic choroidal neovascularization; and diabetic retinopathy in patients with DME, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. She previously led communication for the cardiovascular & metabolism therapeutic area and global commercial strategy organization at Janssen, J&Js pharmaceutical division. and B.S. Gerald Carreau joined Regeneron in 2008 and serves as senior vice president, commercial scale manufacturing and manufacturing technology. Frederick Austin joined Regeneron in 2012 and serves as senior vice president, quality control, Raheen. Dr. Weinreich received his B.S. Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel. Dr. Tessier-Lavigne is also a member of the board of directors of Denali Therapeutics Inc. President Emeritus of Memorial SloanKettering Cancer Center. Regeneron employees attributed a compensation and benefits rating of 4.2/5 stars to their company. Dr. Bassler has previously served as the president of the American Society for Microbiology, as well as on the boards for the American Association for the Advancement of Science, the National Science Foundation and the American Academy of Microbiology. from the University of Pennsylvania and his B.A. Senior Vice President, Clinical Development, Immunology and Inflammation. Co-Founder, President and Chief Executive Officer, Co-Founder, President and Chief Scientific Officer, Senior Vice President, Financial Planning and Analysis. Robert E. Landry joined Regeneron in 2013 and serves as executive vice president, finance and chief financial officer. para nos informar sobre o problema. Highest reported salary offered at Regeneron Pharmaceuticals is $172k. Si continas recibiendo este mensaje, infrmanos del problema Highest Paying Job At Regeneron In Rensselaer, NY Medical Director - $261,089 See Other Titles Highest Paying Department At Regeneron In Rensselaer, NY $115,622 See Other Departments at the State University of New York at Albany and a J.D. Gary Herman, M.D., joined Regeneron in 2015 and leads the early clinical development and experimental sciences (ECDES) function. He co-founded Agios Pharmaceuticals and previously served as a director of Merck and Charles River Laboratories. He has nearly 20 years of experience in the biopharmaceutical industry, where he has held a variety of strategic, business development and finance roles, including in Genentechs Business Development and Corporate Finance departments and in investment banking and equity research at Morgan Stanley and Robertson Stephens. He holds a B.S. Dr. Macdonald is responsible for heading the VelocImmune-NEXT technology development group, neuroscience group, molecular profiling & data sciences group, and DNA core & Aautomation group. He is the former chief executive officer and current chair of the board of Yumanity Therapeutics, Inc. Dr. Coles is also the former president, chief executive officer and chair of the board of Onyx Pharmaceuticals, Inc., and the former president, chief executive officer, and member of the board of directors of NPS Pharmaceuticals, Inc. Senior Vice President, Manufacturing Operations. Research & Science Based on 1040 salaries Research Associate 187 salaries Scientist 119 salaries View More Engineering Based on 355 salaries QC Analyst 28 salaries Engineering Co-Op 12 salaries View More From 2006 to 2007, he served as executive vice president, R&D and technical operations of Crucell Holland B.V., a global biopharmaceutical company. Wir entschuldigen uns fr die Umstnde. Gilead , years of experience working across multiple relevant functions such as Data Science and Computation, systems engineering, high throughput laboratory automation, research biology, and/or drug ZipRecruiter ATS Jobs for ZipSearch/ZipAlerts - 36 days ago, Addison Group - Los Angeles From 1998 until 2004, he held various managerial positions in the health and life sciences practice at Accenture, Ltd., a management consulting business. Senior Vice President, Global Head, Dupixent Franchise.
Allgemein
Posted in
